New Study Discovers Unexpected Reason For Resistance To Cancer Immunotherapy

(MENAFN- Investor Brand Network) A joint team of researchers from the University of Texas MD Anderson Cancer Center, the Karolinska Institutet, and Moffitt Cancer Center has discovered an unexpected mechanism behind resistance to cancer immunotherapy: cancer-induced damage to adjacent nerves .

As more firms like Calidi Biotherapeutics Inc. (NYSE American: CLDI) continue their efforts to...

Read More>>

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text“Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: /Disclaimer

TinyGems
Austin, Texas

512.354.7000 Office
[email protected]

TinyGems is powered by IBN

MENAFN28082025000224011066ID1109988962